Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Travis Johnson

Optometrist Murfreesboro, TN Doctor of Optometry

NPI 1003890609 CMS profile 272462

140 Joe B Jackson Pkwy, Murfreesboro, TN 37127

Open in the dashboard

General payments

$70,710

264 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Travis Johnson of Murfreesboro, TN is reported in the CMS Open Payments database as having received $70,710 across 264 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $162 2
2023 General $9,769 53
2022 General $20,866 88
2021 General $34,611 98
2020 General $3,477 9
2019 General $1,826 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Travis Johnson
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Travis Johnson were reported at $162. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Travis Johnson Optometrist median Middle half National median
2019 $1,826 $159 $67–$371 $163
2020 $3,477 $72 $29–$165 $114
2021 $34,611 $125 $46–$292 $132
2022 $20,866 $162 $66–$374 $149
2023 $9,769 $177 $72–$406 $160
2024 $0 $188 $77–$427 $164
2025 $162 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $68,278 251 payments
  2. Carl Zeiss Meditec, Inc. $2,084 8 payments
  3. Johnson & Johnson Vision Care, Inc. $255 4 payments
  4. New World Medical,Inc. $93 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $31,635 32 payments
  2. Travel and Lodging $16,483 118 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,438 13 payments
  4. Food and Beverage $5,404 98 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,750 3 payments
Products named General payments · program years 2019–2025
  1. TOTAL30 $38,613 147 payments
  2. DAILIES TOTAL1 $28,049 102 payments
  3. Precision 1 $26,475 119 payments
  4. AIR OPTIX Aqua $4,735 24 payments
  5. CIRRUS HD-OCT $1,002 6 payments
  6. Clarus 700 $1,000 1 payment
  7. Humphrey HFA $750 2 payments
  8. AIR OPTIX $482 4 payments
  9. Acuvue $255 4 payments
  10. DAILIES $229 5 payments
  11. Other $361 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

64

Median for Optometry: 120

Drug cost

$2,499

Median for Optometry: $8,864

Branded share of claims

0%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Loteprednol Etabonate Generic 19 $2,337
Latanoprost Generic 45 $163

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$7,430

Medicare's payments for the services billed

Medicare patients

67

Average age 74

Services billed

161

38 women, 29 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 43%
Diabetes 27%
Ischemic heart disease 27%
Chronic kidney disease 25%
Depression 18%
Heart failure 16%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

264 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record